Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial

OBJECTIVE: Management of heavily pre-treated platinum-resistant ovarian cancer remains a therapeutic challenge. Outcomes are poor with non-platinum, single-agent chemotherapy (CT); however, molecularly targeted anticancer therapies provide new options. METHODS: This open-label, investigator-initiate...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung-Yun, Kim, Byoung-Gie, Kim, Jae-Weon, Lee, Jung Bok, Park, Eunhyang, Joung, Je-Gun, Kim, Sunghoon, Choi, Chel Hun, Kim, Hee Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250853/
https://www.ncbi.nlm.nih.gov/pubmed/35320892
http://dx.doi.org/10.3802/jgo.2022.33.e45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250853/
https://www.ncbi.nlm.nih.gov/pubmed/35320892
http://dx.doi.org/10.3802/jgo.2022.33.e45

Ejemplares similares